Billy Dunn’s Prothena board position reignites ethical debate FDA/Regulatory, R&D, Therapeutics Ex-FDA Neuroscience Director Billy Dunn was appointed to Prothena’s board of directors last week. Industry representatives and regulatory experts weigh in on the potential ethical implications. Read more May 23, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/02/FDA-Ad-Com-Comes-Down-Hard-on-Avenues-IV-Tramadol-BioSpace-2-16-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-05-23 08:59:522023-05-23 08:59:52Billy Dunn’s Prothena board position reignites ethical debate
